Compounds > 1-(3-4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine-dihydrochloride

1-(3-4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine-dihydrochloride and Cardiovascular-Diseases

1-(3-4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine-dihydrochloride has been researched along with Cardiovascular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for 1-(3-4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine-dihydrochloride and Cardiovascular-Diseases

Article	Year
American Chemical Society--233rd National Meeting. CNS, cancer and cardiovascular targets. 25-29 March 2007, Chicago, IL, USA. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:5 Topics: Animals; Binding Sites; Cardiovascular Diseases; CD11b Antigen; CD18 Antigens; Diterpenes; Diterpenes, Clerodane; Drug Delivery Systems; Drug Design; Drugs, Investigational; Humans; Integrin alpha4beta1; Lobeline; Mice; Neoplasms; Pain; Piperazines; Quantitative Structure-Activity Relationship; Receptor, PAR-1; Receptors, G-Protein-Coupled; Receptors, Opioid, kappa; Sodium Channel Blockers; Vesicular Monoamine Transport Proteins	2007

Article

Year

American Chemical Society--233rd National Meeting. CNS, cancer and cardiovascular targets. 25-29 March 2007, Chicago, IL, USA.

IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:5

Topics: Animals; Binding Sites; Cardiovascular Diseases; CD11b Antigen; CD18 Antigens; Diterpenes; Diterpenes, Clerodane; Drug Delivery Systems; Drug Design; Drugs, Investigational; Humans; Integrin alpha4beta1; Lobeline; Mice; Neoplasms; Pain; Piperazines; Quantitative Structure-Activity Relationship; Receptor, PAR-1; Receptors, G-Protein-Coupled; Receptors, Opioid, kappa; Sodium Channel Blockers; Vesicular Monoamine Transport Proteins

2007